Navigation Links
Cantel Medical Acquires Jet Prep Ltd.

LITTLE FALLS, N.J., Nov. 6, 2013 /PRNewswire/ -- CANTEL MEDICAL CORP. (NYSE: CMN), has further enhanced its leading endoscopy product portfolio with the acquisition of Jet Prep Ltd.  Based in Herzliya, Israel, Jet Prep Ltd. is the developer of the Jet Prep Flushing Device, a novel single-use irrigation and aspiration catheter to improve visualization during colonoscopy procedures.  The Jet Prep Flushing Device has FDA 510(k) and CE Mark clearances and is ready for immediate commercialization by our global endoscopy sales forces.  The Jet Prep operation, which will be integrated into our Medivators Endoscopy business, will remain in Israel.  Led by David Nitsan, this group of R&D engineers will continue working on new product development.

Don Byrne, President of Medivators Endoscopy, stated, "This acquisition strengthens our position as a leading provider of novel products and solutions for GI endoscopy.  The Jet Prep product is an important addition to our growing portfolio of endoscopy products focused on infection control and improving patient safety and outcomes."

Cantel Medical's Executive Vice President and COO, Jorgen Hansen, added, "We see the Jet Prep product line as exactly the type of novel and highly differentiated product that Medivators should be introducing to the market.  We know there is strong demand from physicians for a unique solution to improving visualization and have high expectations for its success in the GI endoscopy market.  We remain confident in the continued strong growth of our Medivators Endoscopy business."

About Cantel Medical Corp.

Cantel Medical is a leading global company dedicated to delivering innovative infection prevention and control products and services for patients, caregivers, and other healthcare providers which improve outcomes, enhance safety and help save lives.  Our products include specialized medical device reprocessing systems for endoscopy and renal dialysis, advanced water purification equipment, sterilants, disinfectants and cleaners, sterility assurance monitoring products for hospitals and dental clinics, disposable infection control products primarily for dental and GI endoscopy markets, dialysate concentrates, hollow fiber membrane filtration and separation products, and specialty packaging for infectious and biological specimens. Additionally, we provide technical service for our products.  For further information, visit the Cantel website at

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements involve a number of risks and uncertainties, including, without limitation, the risks detailed in Cantel's filings and reports with the Securities and Exchange Commission. Such forward-looking statements are only predictions, and actual events or results may differ materially from those projected or anticipated.


SOURCE Cantel Medical Corp.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Cantel Medical Corp. To Hold Conference Call To Discuss Results For Its Fourth Quarter And Fiscal 2013 Ended July 31, 2013
2. Record Date Of Cantel Medicals Regular Semiannual Dividend Changed To July 23, 2013
3. Cantel Medical Reports EPS of $0.33 vs. $0.30 on 8% Sales Increase for Third Quarter Ended April 30, 2013
4. Cantel Medical Corp. To Hold Conference Call To Discuss Results for Its Third Quarter Ended April 30, 2013
5. Cantel Medical To Present At The Bank Of America Merrill Lynch Health Care Conference
6. Cantel Medical To Present At Needham 12th Annual Healthcare Conference
7. Cantel Medicals Mar Cor Purification Subsidiary Acquires Hemodialysis Water Business from Siemens Water Technologies Business Unit
8. Cantel Medical Reports EPS of $0.38 vs. $0.27 on 9% Sales Increase for Second Quarter Ended January 31, 2013
9. Cantel Medical Reports EPS of $0.35 vs. $0.23 for First Quarter Ended October 31, 2012
10. Cantel Medical Appoints Jorgen B. Hansen As Executive Vice President And Chief Operating Officer
11. Cantel Medical Corp. To Present At The CL King 10th Annual Best Ideas Conference
Post Your Comments:
(Date:6/24/2016)... Mass. , June 24, 2016   Pulmatrix, ... pharmaceutical company developing innovative inhaled drugs, announced today that ... Russell Investments reconstituted its comprehensive set of ... "This is an important milestone for Pulmatrix," ... will increase shareholder awareness of our progress in developing ...
(Date:6/23/2016)... June 23, 2016  MedSource announced today that ... e-clinical software solution of choice.  This latest decision ... value to their clients by offering a state-of-the-art ... relationship establishes nowEDC as the EDC platform of ... full-service clients.  "nowEDC has long been a preferred ...
(Date:6/23/2016)... , June 23, 2016 ... "Pharmaceutical Excipients Market by Type (Organic Chemical (Sugar, ... Formulation (Oral, Topical, Coating, Parenteral) - Global Forecast to ... The global pharmaceutical excipients market ... at a CAGR of 6.1% in the forecast period ...
Breaking Medicine Technology:
(Date:6/27/2016)... ... 2016 , ... recently awarded their highest five-star rating to Best Buy ... in the United States and Canada wear eyeglasses. Once considered to be a purely ... make a fashion statement. Even celebrities use glasses as a way of creating an ...
(Date:6/26/2016)... ... ... blind and certified personal trainer is helping to develop a weight loss fitness plan that ... the two major problems leading the fitness industry today:, , All ... They don’t eliminate all the reasons people quit their exercise program , ...
(Date:6/25/2016)... Viejo, California (PRWEB) , ... June 25, 2016 , ... ... to fit their specific project," said Christina Austin - CEO of Pixel Film Studios. ... fully customizable and all within Final Cut Pro X . Simply select a ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits of moderation, ... the latter, setting the bar too high can result in disappointment, perhaps even self-loathing. ... toward their goal. , Research from reveals that behind the ...
(Date:6/24/2016)... , ... June 24, 2016 , ... ... and Scientific Sessions in Dallas that it will receive two significant new grants ... grants came as PHA marked its 25th anniversary by recognizing patients, medical professionals ...
Breaking Medicine News(10 mins):